Kathryn Powley

Sep 1, 2024 | florey.edu.au | Felicity Lewis |Kathryn Powley

Key pointsNew disease-modifying drugs to treat Alzheimer’s disease are potential game-changers and we want to help with the rollout of those medicines to improve clinical care and research. The Florey is on the cusp of improving the lives of children with severe forms of epilepsy. A new drug for schizophrenia, drug called KarXT, is on the threshold of receiving US Food and Drug Administration approval.

Apr 1, 2024 | florey.edu.au | Kathryn Powley

13 Dec 2023In a world first, Austin Health clinicians have implanted an electrical nerve stimulation device into a patient with Crohn’s disease to prevent inflammation recurring after surgery. The device, developed and manufactured by the Bionics Institute in collaboration with researchers at The Florey and The University of Melbourne, could put Crohn’s sufferersinto long-term remission. Crohn’s disease is a condition that causes inflammation to the lining of the gut.

Mar 21, 2024 | florey.edu.au | Kathryn Powley

22 Mar 2024The Florey is pleased to announce the appointment of the Hon Gabrielle Upton to its Board of Directors. Ms Upton has had a distinguished career as a lawyer, banker, government minister and university Deputy Chancellor. The Hon Gabrielle UptonShe was New South Wales’ first female Attorney General, is a Board Member of Netball Australia, and serves as an Advisory Board Member of the Australian Research Council Centre of Excellence of Quantum Biotechnology.

Dec 15, 2023 | florey.edu.au | Kathryn Powley

15 Dec 2023Researchers at The Florey have received a combined $13.8 million to support research that seeks to improve understanding and find treatments for a range of brain and mental health conditions. Health Minister Mark Butler announced the funding as part of the National Health and Medical Research Council’s Investigator Grants and Ideas Grants. Florey Director Trevor Kilpatrick said Florey researchers are solving some of the biggest challenges in neuroscience and mental health.

Sep 14, 2023 | florey.edu.au | Kathryn Powley

15 Sep 2023A human-machine hybrid model applied to prediction markets has the potential to improve responses to emerging risks, such as pandemics or climate change. Researchers and data scientists at The Florey have found a way to harness artificial intelligence (AI) to improve people’s accuracy at forecasting future events. The team used AI to enhance the accuracy of crowd-sourced forecasts on a prediction market platform.